Search Results 211-220 of 10253 for Brugada pattern

  1. A Study to Evaluate the Safety and Effectiveness of SAR442168 Compared to Placebo in Primary Progressive Multiple Sclerosis (PPMS) Patients - Mayo Clinic

    A Study to Evaluate the Safety and Effectiveness of SAR442168 Compared to Placebo in Primary Progressive Multiple Sclerosis (PPMS) Patients. Print details.

  2. PTT-936, An Alpha Kinase 1 (ALPK1) Activator, Alone Or In Combination With Anti-PD-1/L1 In Patients With Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

    PTT-936, An Alpha Kinase 1 (ALPK1) Activator, Alone Or In Combination With Anti-PD-1/L1 In Patients With Locally Advanced Or Metastatic Solid Tumors. Print ...

  3. Cardiac ablation - Care at Mayo Clinic

    For example, they use cardiac mapping systems, such as ... Related. Arrhythmogenic cardiomyopathy · Atrial fibrillation · Atrial flutter · Brugada syndrome ...

  4. VDI’s Ultra-High Frequency Electrocardiogram (UHF-ECG) For The Diagnosis Of Ventricular Electrical Dyssynchrony (VED) - Mayo Clinic

    VDI's Ultra-High Frequency Electrocardiogram (UHF-ECG) For The Diagnosis Of Ventricular Electrical Dyssynchrony (VED). Print details. Share; Facebook · Twitter.

  5. Safety And Efficacy Study Of The Medtronic CoreValve® System In The Treatment Of Severe, Symptomatic Aortic Stenosis In Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). - Mayo Clinic

    Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab Title Description.

  6. Publications - David Abia Trujillo, M.D., M.B. - Mayo Clinic

    Cryobiopsy versus fine-needle aspiration for shape-sensing robotic-assisted sampling of small lung nodules. Lung Cancer. 2024 Oct; 196:107967 Epub 2024 Sept ...

  7. OPX Saliva Biomarker Study - Mayo Clinic

    OPX Saliva Biomarker Study. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  8. Randomized, Open Label, Clinical Study Of The Targeted Therapy, Palbociclib, To Treat Metastatic Breast Cancer

    Randomized, Open Label, Clinical Study Of The Targeted Therapy, Palbociclib, To Treat Metastatic Breast Cancer. Print details ... QTc interval > 480 msec, Brugada ...

  9. Publications - Stacey A. Rizza, M.D. - Mayo Clinic

    Publications. Print. Higgins E, Yuan J, Lange S, Boilson BA, Pritt BS, Rizza SA.

  10. Study Of Durvalumab And Tremelimumab As First-line Treatment In Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

    Study Of Durvalumab And Tremelimumab As First-line Treatment In Patients With Advanced Hepatocellular Carcinoma (HIMALAYA). Print details ... syndrome, or ...